Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ligustilide SCHEMBL4087024 | 1.00 | TRPA1 (1.00) | TRPA1ALDH1A1TSHRMAPK1 | |
| Ligustilide SCHEMBL28151404 | 1.00 | TRPA1 (1.00) | TRPA1ALDH1A1TSHRMAPK1 | |
| Ligustilide SCHEMBL11967666 | 1.00 | TRPA1 (1.00) | TRPA1ALDH1A1TSHRMAPK1 | |
| Ligustilide SCHEMBL27599046 | 0.90 | TRPA1 (0.81) | TRPA1 | |
| SCHEMBL3762680 | 0.81 | TRPA1 (0.68) | TRPA1 | |
| SCHEMBL11967655 | 0.76 | TRPA1 (0.61) | TRPA1 | |
| SCHEMBL28204511 | 0.73 | TRPA1 (0.57) | TRPA1 | |
| SCHEMBL28216731 | 0.73 | TRPA1 (0.57) | TRPA1 | |
| SCHEMBL1872402 | 0.71 | TRPA1 (0.54) | TRPA1ALDH1A1 | |
| SCHEMBL18843936 | 0.71 | TRPA1 (0.55) | TRPA1ALDH1A1TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240269196-A1 | RESPIRATORY TREATMENTS USING SALMONID OIL COMPOSITIONS | HOFSETH BIOCARE ASA (NO) | 2024-08-15 | — | — | US | claimed |
| EP-4247165-A1 | RESPIRATORY TREATMENTS | Hofseth Biocare ASA (NO) | 2023-09-27 | — | — | EP | claimed |
| EP-4132571-A1 | RESPIRATORY TREATMENTS USING SALMONID OIL COMPOSITIONS | Hofseth Biocare ASA (NO) | 2023-02-15 | — | — | EP | claimed |
| CN-115427067-A | Respiratory therapy using salmon oil compositions | 霍夫赛思生物保健有限公司 | 2022-12-02 | — | — | CN | claimed |
| WO-2022108883-A1 | RESPIRATORY TREATMENTS | HOFSETH BIOCARE ASA (NO) | 2022-05-27 | — | — | WO | claimed |
| US-20210315941-A1 | RESPIRATORY TREATMENTS USING SALMONID OIL COMPOSITIONS | HOFSETH BIOCARE ASA (NO) | 2021-10-14 | — | — | US | claimed |
| EP-3165222-B1 | USE OF PHTHALIDE COMPOUND | EVERFRONT BIOTECH INC (TW) | 2020-03-11 | — | — | EP | claimed |
| CN-109307721-A | A kind of HPLC-QQQ/MS method measures the detection method of content of effective component in Dragon groundnut | 陕西步长制药有限公司 | 2019-02-05 | — | — | CN | claimed |
| CN-105213370-B | Application of phthalide compound | 长弘生物科技股份有限公司 | 2018-10-09 | — | — | CN | claimed |
| EP-2974723-B1 | APPLICATION OF PHTHALIDE COMPOUNDS | HAWKING BIOLOGICAL TECH CO LTD (TW) | 2018-04-11 | — | — | EP | claimed |
| CN-105213370-A | Application of phthalide compound | EVERFRONT BIOTECH INC | 2016-01-06 | — | — | CN | claimed |
| CN-105067750-A | Method used for determining lactone ingredients content in naofentai soft capsules | SHNAGHAI HAIHONG INDUSTRY GROUP CHAOHU C DRAGON PHARMACY CO LTD | 2015-11-18 | — | — | CN | claimed |
| CN-104991033-A | Method for measuring components of essential oil of ligusticum wallichii through quantitative analysis of multi-components by single marker | SHANGHAI HAIHONG GROUP CHAOHU C DRAGON PHARMACEUTICAL CO LTD | 2015-10-21 | — | — | CN | claimed |
| WO-2014139318-A1 | APPLICATION OF PHTHALIDE COMPOUND | 国钦生物科技股份有限公司 (CN) | 2014-09-18 | — | — | WO | claimed |
| US-20140271568-A1 | METHOD AND KIT FOR PROVIDING AN INCREASED EXPRESSION OF TELOMERASE, BRAIN-DERIVED NEUROTROPHIC FACTOR, STROMAL CELL-DERIVED FACTOR-1, CXC CHEMOKINE RECEPTOR 4, AND/OR IMMUNE REGULATORY FACTOR OF STEM CELL | Hawking Biological Technology Co., Ltd (TW) | 2014-09-18 | — | — | US | claimed |
| CN-104042606-A | APPLICATION OF PHTHALIDE COMPOUND | HAWKING BIOLOG TECHNOLOGY CO LTD | 2014-09-17 | — | — | CN | claimed |
| CN-102657666-B | Medical application of 1,2,3,4,6-O-pentagalloylglucose and composition thereof in preparation of demulcent medicaments | UNIV CHINA PHARMA | 2013-06-12 | — | — | CN | claimed |
| EP-1993580-A1 | COMBINATION THERAPY FOR TREATMENT OF PATIENTS WITH NEUROLOGICAL DISORDERS AND CEREBRAL INFARCTION | Moleac Pte Ltd. (SG) | 2008-11-26 | — | — | EP | claimed |
| WO-2007106049-A1 | COMBINATION THERAPY FOR TREATMENT OF PATIENTS WITH NEUROLOGICAL DISORDERS AND CEREBRAL INFARCTION | MOLEAC PTE LTD (SG) | 2007-09-20 | — | — | WO | claimed |
| CN-1569848-A | Ligustilide for treating ischemic heart disease and its preparing method | INST OF CHINESE MATERIA MEDICA (CN) | 2005-01-26 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140271568-A1 | METHOD AND KIT FOR PROVIDING AN INCREASED EXPRESSION OF TELOMERASE, BRAIN-DERIVED NEUROTROPHIC FACTOR, STROMAL CELL-DERIVED FACTOR-1, CXC CHEMOKINE RECEPTOR 4, AND/OR IMMUNE REGULATORY FACTOR OF STEM CELL | CXCL12, CXCR4, BDNF | TRPA1 2589/4885ALDH1A1 444/4885TSHR 931/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.